MolDX: Genetic Testing for Hereditary Thrombophilia

Hereditary thrombophilia genetic testing is covered for germline tests that will inform VTE management when the patient has VTE associated with ASH-defined non-surgical major transient or hormonal risk factors, or presents with cerebral or splanchnic venous thrombosis where testing will affect long-term anticoagulation. Covered tests must include ASH-guideline-supported minimum genetic content (or a single known familial variant), be limited to validated content, not conflict with repeat germline testing policy L38429, and must have completed a MolDX Technical Assessment.

"Genetic testing for hereditary thrombophilia is covered when the patient has venous thromboembolism (VTE) and the VTE is associated with non-surgical major transient or hormonal risk factors as def..."

Sign up to see full coverage criteria, indications, and limitations.